• 1
    Brodeur GM, Castleberry RP. Neuroblastoma. In: PizzoPA, PoplackDG, eds. Principles and practice of pediatric oncology, Chapter 29, 3rd edn. Philadelphia, PA: Lippincott-Raven Publishers, 1997. 76183.
  • 2
    Vasudevan SA, Nuchtern JG. Gene profiling of high risk neuroblastoma. World J Surg 2005; 29: 31724.
  • 3
    Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003; 3: 20316.
  • 4
    Ara T, DeClerck YA. Mechanisms of invasion and metastasis in human neuroblastoma. Cancer Metastasis Rev 2006; 25: 64557.
  • 5
    Fidler IJ. Critical determinants of metastasis. Semin Cancer Biol 2002; 12: 8996.
  • 6
    Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006; 127: 67995.
  • 7
    Nevo I, Sagi-Assif O, Edry Botzer L, Amar D, Maman S, Kariv N, Leider-Trejo LE, Savelyeva L, Schwab M, Yron I, Witz IP. Generation and characterization of novel local and metastatic human neuroblastoma variants. Neoplasia 2008; 10: 81627.
  • 8
    Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R, Ernestus K, Konig R, Haas S, Eils R, Schwab M, Brors B, et al. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol 2006; 24: 50708.
  • 9
    Pietsch T, Gottert E, Meese E, Blin N, Feickert HJ, Riehm H, Kovacs G. Characterization of a continuous cell line (MHH-NB-11) derived from advanced neuroblastoma. Anticancer Res 1988; 8: 132933.
  • 10
    Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C, Meltzer PS. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001; 7: 6739.
  • 11
    Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S, Guo N, Muruganujan A, Doremieux O, Campbell MJ, Kitano H, Thomas PD. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005; 33: D284D288.
  • 12
    Dennis G,Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003; 4: P3.
  • 13
    Guda C, Subramaniam S. pTARGET [corrected] a new method for predicting protein subcellular localization in eukaryotes. Bioinformatics 2005; 21: 39639.
  • 14
    Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J. Genes that mediate breast cancer metastasis to lung. Nature 2005; 436: 51824.
  • 15
    Morikawa K, Walker SM, Jessup JM, Fidler IJ. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res 1988; 48: 19438.
  • 16
    Bruns CJ, Harbison MT, Kuniyasu H, Eue I, Fidler IJ. In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. Neoplasia 1999; 1: 5062.
  • 17
    Onn A, Isobe T, Itasaka S, Wu W, O'Reilly MS, Ki Hong W, Fidler IJ, Herbst RS. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin Cancer Res 2003; 9: 55329.
  • 18
    Myers JN, Holsinger FC, Jasser SA, Bekele BN, Fidler IJ. An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Cancer Res 2002; 8: 2938.
  • 19
    Thomas PD, Kejariwal A, Guo N, Mi H, Campbell MJ, Muruganujan A, Lazareva-Ulitsky B. Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res 2006; 34: W645W650.
  • 20
    Mathupala SP, Ko YH, Pedersen PL. Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 2006; 25: 477786.
  • 21
    Pedersen PL. Warburg, me and Hexokinase 2: multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the “Warburg Effect”, i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr 2007; 39: 21122.
  • 22
    Kattan Z, Marchal S, Brunner E, Ramacci C, Leroux A, Merlin JL, Domenjoud L, Dauca M, Becuwe P. Damaged DNA binding protein 2 plays a role in breast cancer cell growth. PLoS One 2008; 3: e2002.
  • 23
    Wittschieben BO, Wood RD. DDB complexities. DNA Repair (Amst) 2003; 2: 10659.
  • 24
    Hannigan BM, Barnett YA, Armstrong DB, McKelvey-Martin VJ, McKenna PG. Thymidine kinases: the enzymes and their clinical usefulness. Cancer Biother 1993; 8: 18997.
  • 25
    Munch-Petersen B, Cloos L, Jensen HK, Tyrsted G. Human thymidine kinase 1. Regulation in normal and malignant cells. Adv Enzyme Regul 1995; 35: 6989.
  • 26
    Citi S, Amorosi A, Franconi F, Giotti A, Zampi G. Cingulin, a specific protein component of tight junctions, is expressed in normal and neoplastic human epithelial tissues. Am J Pathol 1991; 138: 7819.
  • 27
    Ohnishi H, Nakahara T, Furuse K, Sasaki H, Tsukita S, Furuse M. JACOP, a novel plaque protein localizing at the apical junctional complex with sequence similarity to cingulin. J Biol Chem 2004; 279: 4601422.
  • 28
    Li L, Hung AC, Porter AG. Secretogranin II: a key AP-1-regulated protein that mediates neuronal differentiation and protection from nitric oxide-induced apoptosis of neuroblastoma cells. Cell Death Differ 2008; 15: 87988.
  • 29
    Fontan-Gabas L, Oliemuller E, Martinez-Irujo JJ, de Miguel C, Rouzaut A. All-trans-retinoic acid inhibits collapsin response mediator protein-2 transcriptional activity during SH-SY5Y neuroblastoma cell differentiation. FEBS J 2007; 274: 498511.
  • 30
    Kodama Y, Murakumo Y, Ichihara M, Kawai K, Shimono Y, Takahashi M. Induction of CRMP-2 by GDNF and analysis of the CRMP-2 promoter region. Biochem Biophys Res Commun 2004; 320: 10815.
  • 31
    Glass TL, Raabe TD, Garcia DM, Koke JR. Phosphorylated neurofilaments and SNAP-25 in cultured SH-SY5Y neuroblastoma cells. Brain Res 2002; 934: 438.
  • 32
    Oyler GA, Polli JW, Higgins GA, Wilson MC, Billingsley ML. Distribution and expression of SNAP-25 immunoreactivity in rat brain, rat PC-12 cells and human SMS-KCNR neuroblastoma cells. Brain Res Dev Brain Res 1992; 65: 13346.
  • 33
    Schmitt-Graff A, Muller H, Rancso C, Ahnert-Hilger G, John M, Riecken EO, Stein H, Wiedenmann B. [Molecules of regulated secretion are differentiation markers of neuroendocrine tumors]. Verh Dtsch Ges Pathol 1997; 81: 15761.
  • 34
    Wen W, Taylor SS, Meinkoth JL. The expression and intracellular distribution of the heat-stable protein kinase inhibitor is cell cycle regulated. J Biol Chem 1995; 270: 20416.
  • 35
    Oehlrich N, Devitt G, Linnebacher M, Schwitalle Y, Grosskinski S, Stevanovic S, Zoller M. Generation of RAGE-1 and MAGE-9 peptide-specific cytotoxic T-lymphocyte lines for transfer in patients with renal cell carcinoma. Int J Cancer 2005; 117: 25664.
  • 36
    Chang R, Xu X, Li MD. Molecular cloning, mapping and characterization of a novel mouse RING finger gene, Mrf1. Gene 2002; 291: 2419.
  • 37
    Cheung NV, Cohn SL. Neuroblastomaed. Heidelberg, Germany: Springer, 2005.
  • 38
    Cowie F, Corbett R, Pinkerton CR. Lung involvement in neuroblastoma: incidence and characteristics. Med Pediatr Oncol 1997; 28: 42932.
  • 39
    Towbin R, Gruppo RA. Pulmonary metastases in neuroblastoma. AJR Am J Roentgenol 1982; 138: 758.
  • 40
    Kammen BF, Matthay KK, Pacharn P, Gerbing R, Brasch RC, Gooding CA. Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis. AJR Am J Roentgenol 2001; 176: 7559.
  • 41
    Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, et al. Molecular portraits of human breast tumours. Nature 2000; 406: 74752.
  • 42
    Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 2003; 100: 159015.
  • 43
    Thomas PD, Mi H, Lewis S. Ontology annotation: mapping genomic regions to biological function. Curr Opin Chem Biol 2007; 11: 411.
  • 44
    Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008; 13: 47282.
  • 45
    Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet 2007; 8: 34152.
  • 46
    Mathupala SP, Ko YH, Pedersen PL. Hexokinase-2 bound to mitochondria: cancer's stygian link to the “Warburg Effect” and a pivotal target for effective therapy. Semin Cancer Biol 2009; 19: 1724.
  • 47
    Xu L, Shen SS, Hoshida Y, Subramanian A, Ross K, Brunet JP, Wagner SN, Ramaswamy S, Mesirov JP, Hynes RO. Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol Cancer Res 2008; 6: 7609.
  • 48
    Halachmi E, Witz IP. Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity. Cancer Res 1989; 49: 23839.